EUROLAB
iso-10993-7-ethylene-oxide-residuals
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ISO 10993-7 Ethylene Oxide Residuals Laboratory Testing Service: A Comprehensive Guide

ISO 10993-7 is an international standard that outlines the requirements for testing medical devices for ethylene oxide residuals. The standard is part of the ISO 10993 series, which provides guidelines for the biological evaluation of medical devices. In this section, we will provide a comprehensive overview of the relevant standards, legal and regulatory framework, and standard development organizations.

Relevant Standards

  • ISO 10993-7:2008(E) - Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals

  • ASTM F2004-09 - Standard Guide for Selecting Castes Suitable for Use as Biological Indicators in Sterilization Processes

  • EN 556-1:2017 - Medical devices. Requirements for labeling and packaging for the detection of certain substances (e.g., ethylene oxide) on or in medical devices

  • TSE L14:2016 - Medical devices. Ethylene oxide sterilization residuals

    • Legal and Regulatory Framework

    The use of ethylene oxide for sterilizing medical devices is regulated by various international, national, and regional authorities. These regulations require manufacturers to demonstrate that their products meet specific standards for biocompatibility and safety.

  • The European Unions Medical Device Regulation (MDR) requires manufacturers to conduct testing in accordance with ISO 10993-7

  • The US FDAs Quality System Regulation (QSR) outlines the requirements for demonstrating compliance with ISO 10993-7

  • The International Organization for Standardization (ISO) provides a framework for developing and implementing standards for medical devices

    • Standard Development Organizations

    The development of standards is a collaborative effort between various organizations, including:

  • ISO: Provides a framework for standardization in various industries, including medical devices

  • ASTM: Develops standards for materials, products, and services, including those related to medical devices

  • EN: European Committee for Standardization develops standards for the European market

  • TSE: Turkish Standards Institution develops standards for the Turkish market

    • Standard Evolution and Updates

    Standards are constantly evolving as new technologies and research become available. The development process typically involves:

    1. Identifying a need for a standard or update to an existing standard

    2. Gathering input from stakeholders, including industry experts, regulatory authorities, and consumers

    3. Developing a draft document outlining the requirements and procedures

    4. Reviewing and revising the draft based on feedback from stakeholders

    5. Finalizing the standard and making it available for public use

    Standard Numbers and Scope

  • ISO 10993-7:2008(E) - Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals (Scope: Provides requirements and guidelines for testing medical devices for ethylene oxide residuals)

  • ASTM F2004-09 - Standard Guide for Selecting Castes Suitable for Use as Biological Indicators in Sterilization Processes (Scope: Outlines a guide for selecting castes suitable for use as biological indicators in sterilization processes)

    • Standard Compliance Requirements

    Compliance with ISO 10993-7 is mandatory for manufacturers of medical devices that have been sterilized using ethylene oxide. Failure to comply may result in:

  • Regulatory penalties and fines

  • Product recalls or withdrawals from the market

  • Damage to reputation and brand value

    • Industries Requiring This Testing

    This testing service is required by various industries, including:

  • Medical device manufacturers (e.g., implants, instruments, accessories)

  • Pharmaceutical companies (e.g., packaging materials, equipment)

  • Biotechnology firms (e.g., cell culture media, bioreactors)

    • The consequences of not performing this test can be severe, including product recalls, regulatory penalties, and damage to reputation.

    Business and Technical Reasons for Conducting ISO 10993-7 Testing

    Conducting ISO 10993-7 testing is essential for several business and technical reasons:

  • Ensures compliance with regulatory requirements

  • Demonstrates commitment to quality and safety

  • Minimizes risk of product recalls and regulatory penalties

  • Enhances reputation and brand value

    • Risk Factors and Safety Implications

    The use of ethylene oxide in sterilization processes poses risks to human health, including:

  • Carcinogenic effects

  • Mutagenic effects

  • Neurotoxicity

  • Respiratory problems

    • ISO 10993-7 testing helps mitigate these risks by ensuring that medical devices meet specific standards for biocompatibility and safety.

    Quality Assurance and Quality Control Aspects

    ISO 10993-7 testing involves a range of quality assurance and quality control measures, including:

  • Sample preparation and handling

  • Testing equipment calibration and validation

  • Data collection and analysis

  • Reporting and documentation

    • These measures ensure that test results are accurate and reliable.

    Competitive Advantages and Cost-Benefit Analysis

    Conducting ISO 10993-7 testing provides several competitive advantages, including:

  • Enhanced reputation and brand value

  • Compliance with regulatory requirements

  • Reduced risk of product recalls and regulatory penalties

  • Improved quality and safety

    • The cost-benefit analysis of conducting ISO 10993-7 testing demonstrates that the benefits far outweigh the costs.

    Conclusion

    ISO 10993-7 is an essential standard for testing medical devices for ethylene oxide residuals. The standard provides guidelines for demonstrating compliance with regulatory requirements, ensuring product safety, and minimizing risk. Manufacturers must conduct this testing to ensure compliance with regulatory requirements, maintain a commitment to quality and safety, and minimize the risk of product recalls and regulatory penalties.

    In the next section, we will discuss the testing process and procedures outlined in ISO 10993-7.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers